Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Repurposing immunosuppressants for antileukemia therapy
Maiko Sezaki,
Gang Huang
Department of Cell Systems & Anatomy
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Repurposing immunosuppressants for antileukemia therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Inosinate Dehydrogenase Inhibitor
100%
Combination Therapy
50%
Immunosuppressive Drug
50%
Drug
50%
Chemotherapeutic Agent
50%
Drug Therapy
25%
Upregulation
25%
Acute Myeloid Leukemia
25%
Therapy Effect
25%
Health Care Cost
25%
Development
25%
Attention
25%
Drug Repositioning
25%
TLR Signaling
25%
Base
25%
Hematological Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inosinate Dehydrogenase Inhibitor
100%
Immunosuppressive Agent
50%
Drug
50%
Acute Myeloid Leukemia
25%
Base
25%
Neuroscience
Inosine-5′-monophosphate dehydrogenase
100%
Myeloid
25%
TLR Signaling
25%
Biochemistry, Genetics and Molecular Biology
Upregulation
25%
Development
25%
Myeloid
25%
TLR Signaling
25%
Attention
25%
Molecular Medicine
25%